The California Supreme Court Doles out a Win to Plaintiffs with PAGA Claims

As a result of the recent case, Williams v. Superior Court (July 13, 2017, No. S227228) ___Cal.4th___ [2017 Cal. LEXIS 5124], employees received a big win on PAGA (Private Attorney General Act) class action claims.  Read More ›

Ninth Circuit Overturns Dismissal Of False Claims Case Against Gilead, Clarifies Types Of Falsity That Give Rise To Liability

On July 7, the Ninth Circuit issued an opinion in United States ex rel. Campie v. Gilead Sciences, laying out the standards for pleading plausible claims under Fed. R. Civ. P. 12(b)(6) in whistleblower cases filed under the False Claims Act.  United States ex rel. Campie v. Gilead Sciences, 2017 U.S. App. LEXIS 12163 (9th Cir. July 7, 2017) (“Campie”). Read More ›

AB 488: Expansion of FEHA’s Definition of “Employee” Is Part of Employee-Centered Legal Trend

The California Fair Employment and Housing Act (FEHA) protects the right to seek, obtain, and hold employment without discrimination because of race, religion, sex, age, disability, or sexual orientation, among other characteristics.  Under the FEHA, the definition of “employee” in Section 12926 of the Government Code previously excluded individuals with disabilities granted special licenses to work at nonprofit sheltered workshops, day programs, or rehabilitation facilities.  Employers are still permitted to pay these individuals less than the minimum wage, but before January 1, 2017, there was no recourse under FEHA if these individuals were being discriminated against or harassed.  Now, they are afforded the same FEHA protections, thanks to Assembly Bill No. 488. Read More ›

California’s Nursing Homes Place Profits Over Employee and Resident Rights

Tens of thousands of Californians work in the state’s Skilled Nursing Facilities (“SNF”) and Assisted Living Facilities (“RCFE”).  Much of this workforce is underpaid and overworked.  Workers who care for senior citizens are the front line for preventing abuse and neglect.  Sadly, the companies that employ these workers frequently place hard working nursing staff, including Registered Nurses (“RNs”) and Licensed Vocational Nurses (“LVNs”) and Physical and Occupational Therapists in difficult if not impossible situations because they place profits over quality care.  When elder abuse occurs employers are often quick to blame low level staff when the root cause of the abuse is systematic under-staffing and poor training. Read More ›

U.S. Supreme Court Speaks on the False Claims Act

On December 6, 2016, the U.S. Supreme Court, in State Farm Fire & Cas. Co. v. United States ex rel. Rigsby, Docket No. 15-513, slip op. (S.Ct. December 6, 2016) (“State Farm v. Rigsby”), found that failure to keep a False Claims Act (“FCA”) complaint under seal for the required 60 days was not sufficient to warrant a dismissal with prejudice.   Read More ›

Drug Addiction Rehabilitation Scams Profit Off of Addicts and Insurance

As drug addiction in the United States continues to gain national attention, the drug addiction rehabilitation industry booms. The Substance Abuse and Mental Health Services Administration estimates the addiction rehabilitation market is about $35 billion each year. While most of the industry provides life saving services for individuals struggling with addiction, some run scams to profit off of addicts and their insurance policies. Read More ›

Mylan Business Practices Harm Consumers, Insurers and the Government

Mylan NV's EpiPen has made headlines recently, and not in a positive way. Outrage grew in August at a jaw dropping 500% price hike for its EpiPen epinephrine auto injectors. The EpiPen is a lifesaving device used to treat severe allergic reactions, or anaphylaxis. The device is essentially a spring loaded syringe that injects a dose of epinephrine into the thigh, even through clothing.  Read More ›

Compounded Drug Fraud

Drug compounding is the process by which a pharmacist combines or alters ingredients to make medications tailored to individual patient needs. Common examples include putting medication in liquid form for elderly patients or excluding an allergen. Many people benefit from these services.  Read More ›

Seventh Circuit Holds Medicare Part D is Entitled to Lower Prices Offered by Pharmacies to Patients under Discount Programs

The issue of what constitutes a medical provider’s “usual and customary” price has been at the center of a litany of false claims act litigation, at both the state and federal levels.  When dealing with prescription drugs paid for by Medicare Part D, CMS states “where a pharmacy offers a lower price to customers throughout a benefit year” the lower price is considered the “usual and customary” price rather than “a one-time ‘lower cash’ price.” Read More ›

Ninth Circuit Limits Public Disclosure Defense

In federal and California state courts, defendants often look to the “public disclosure bar,” 31 U.S.C. § 3730(e)(4)(A) and Cal. Gov. Code section 12652, subd. (d)(3)(A), to shield them from liability from claims brought under the Federal and California False Claims Acts. Not surprisingly, defendants routinely argue that the public disclosure bar should be broadly construed to bar claims that are only tangentially related to information publicly disclosed before the whistleblower (also called the “relator”) filed their false claims action. Read More ›